HALISTER: Bristol-Myers’s Immunotherapy Improves Survival in Lung Cancer

Bristol-Myers’s Immunotherapy Improves Survival in Lung Cancer

Alert: HALISTER Source: BN (Bloomberg News)

Tickers BMY US (Bristol-Myers Squibb Co) NOVN VX (Novartis AG) ROG VX (Roche Holding AG)

People Fouad Namouni (Bristol-Myers Squibb Co) Seamus Fernandez (Leerink Swann & Co Inc)

Topics Cancers Lung Cancer Respiratory Illnesses

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283